Olema Pharmaceuticals Current Deferred Revenue (Quarterly) Trends

Olema Pharmaceuticals, Inc. (OLMA)

25.29 -0.35 (-1.37%) USD | NASDAQ | Dec 30, 14:12

View Current Deferred Revenue (Quarterly) for OLMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Cidara Therapeutics, Inc.	--
Cogent Biosciences, Inc.	--
Replimune Group, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade